Top News

Blog Post | March 15, 2018
Doctors take an oath to “First, do no harm.” Medical technology companies make the same pledge. In fact, I'd say the industry’s commitment to helping patients live longer, healthier, more productive lives is matched only by its dedication to quality and safety.
Blog Post | March 6, 2018
Recently, researchers at Brigham and Women’s Hospital published an article in JAMA Oncology that sought to compare the performance of FDA-approved companion diagnostics (FDA-CDs) and laboratory-developed tests (LDTs). In recent years, public debate and scrutiny has intensified regarding the oversight paradigm for diagnostics as well as the highly disparate treatment of tests that are the same from the perspective of patient risk and safety.
Press Release | March 6, 2018
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that it has closed a transaction to fully own and operate The MedTech Conference, the premier global gathering of the medical technology industry.


April 4, 2018 to April 5, 2018
| Washington, DC
How do you implement and measure the effectiveness of a complaint handling system covering a diverse set of possible products and problems? How are complaint files managed across multiple domestic... Read More
April 23, 2018 to April 24, 2018
| Washington, DC
AdvaMed’s 4th Annual Payment Policy Conference will convene device manufacturers, hospitals, insurers, CMS, and Capitol Hill for an in-depth discussion and analysis of the reimbursement and coverage... Read More

Industry News

PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States. 
Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.
PR Newswire
Royal Philips, a global leader in health technology, today announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians' use of Azurion resulted in significant time savings for the hospital, including a 17...

Twitter Feed

March 16, 2018 - 3:20pm
Pain affects more Americans than diabetes, heart disease and cancer combined. It is cited as the most common reason…
March 15, 2018 - 5:00pm
RT : As we commemorate Patient Safety Awareness Week, it's important to understand just how much goes into making sure t…